StockData
NewcelX Ltd. logo

NewcelX Ltd. (NCEL) stock

NCELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 4/30
$2.54−0.15 (-5.58%)

Close on Nov 20, 2026Market cap $12.19MP/E 1.2Yield –

NewcelX total assets

Total assets on the balance sheet at the end of each period.

NewcelX's total assets was $9.70M at Jun 30, 2026. For fiscal 2025 it was $11.45M, up 1167.4% from the year before. The highest annual figure on record is $11.45M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$11.45M+1167.4%
FY2024Dec 31, 2024$903.00K-51.1%
FY2023Dec 31, 2023$1.85M-80.1%
FY2022Dec 31, 2022$9.28M+60.9%
FY2021Dec 31, 2021$5.76M+375.8%
FY2020Dec 31, 2020$1.21M+74.0%
FY2019Dec 31, 2019$696.43K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$9.70M+712.8%
Q4 FY2025Dec 31, 2025$11.45M+519.8%
Q2 FY2025Jun 30, 2025$4.34M+91.1%
Q4 FY2024Dec 31, 2024$903.00K-90.3%
Q2 FY2024Jun 30, 2024$1.19M-42.0%
Q4 FY2023Dec 31, 2023$1.85M-68.0%
Q2 FY2023Jun 30, 2023$2.27M-72.5%
Q4 FY2022Dec 31, 2022$9.28M+665.7%
Q2 FY2022Jun 30, 2022$2.06M+195.5%
Q4 FY2021Dec 31, 2021$5.76M–
Q2 FY2021Jun 30, 2021$8.27M–
Q4 FY2020Dec 31, 2020$1.21M–
Q4 FY2019Dec 31, 2019$696.43K–

More NewcelX figures

See a number that looks wrong?